bf/NASDAQ:APM_icon.jpeg

NASDAQ:APM

Aptorum Group Limited

  • Stock

0.92

−2.02%

−0.50

USD last updated 05/08 01:57:14

Last Close

1.42

04/08 21:51

Market Cap

19.48M

Beta: −0.02

Volume Today

15.84K

Avg: 12.53K

PE Ratio

−0.10

PFCF: −0.49

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of corona...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -8-6-4-2242018-06-292019-12-302021-04-192022-09-302023-12-222024-12-19

    Revenue (Estimate*)

    5M10M15M20M2018-06-292019-12-302021-04-192022-09-302023-12-222024-12-19

    *Estimate based on analyst consensus